Skip to main content
Clinical Trials/NCT02128854
NCT02128854CompletedNot Applicable

Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills

Medical University of South Carolina1 site in 1 country60 target enrollmentStarted: August 14, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
Physical Activity Score on the Global Physical Activity Questionnaire

Study Overview

Brief Summary

The purpose of this project is two-fold: (1) to determine the feasibility of recruiting rural African American (AA) adults in South Carolina (SC) for assessing the usefulness of tablet-based resources in good diabetes self-management behaviors, and (2) to test a tablet-aided intervention for improving diabetes self-management behaviors

Detailed Description

The proposed study will assess the feasibility of recruitment of African American adults residing in rural South Carolina who will assist with improving the usability of tablet computers. In addition, we will implement a pilot trial of the TABLETS (Tablet-Aided BehavioraL intervention Effect on Self-management skills) intervention for diabetes, using motivational strategies, among rural African Americans. The proposed project is designed to address 3 important issues: recruitment for a hard-to-reach population, utility of technology-enabled intervention, and development of a tablet-aided intervention tailored to understand best practices for diabetes self-management

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Investigator)

Eligibility Criteria

Ages
45 Years to 100 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age ≥45 years
  • •Clinical diagnosis of diabetes with HbA1c ≥8% and either diagnosis of hyperlipidemia with LDL >100mg/dL or hypertension with BP >140/80mmHg
  • •Self-identified as African American
  • •Residence in a 4G cellular service area
  • •Able to communicate in English

Exclusion Criteria

  • •Cognitive impairment
  • •Active alcohol or drug abuse/dependency
  • •Acute decompensation of chronic conditions precluding participation
  • •Participation in other diabetes clinical trials
  • •A life expectancy <6 months

Arms & Interventions

Tablets Intervention

Experimental

Individuals randomized to this arm will receive: 1) peripheral devices for monitoring blood glucose, blood pressure, and weight; 2) 8 weekly tablet-delivered education and skills training sessions; 3) two booster sessions delivered via tablet-based videoconferencing at 3 and 6 months.

Intervention: Tablets Intervention (Behavioral)

Usual Care

No Intervention

Apart from study visits, individuals randomized to the Usual Care group will receive usual care for diabetes management as provided by their primary care physician. The provider will be responsible for determining changes in the treatment regimen and determining the timing of follow-up visits for diabetes care. Between scheduled office encounters, contact will be initiated by the individual.

Outcomes

Primary Outcomes

Physical Activity Score on the Global Physical Activity Questionnaire

Time Frame: 6 months post-randomization

Information will be collected to assess physical activity in three domains and sedentary behaviors.

Medication Adherence on the Morisky Medication Adherence Scale

Time Frame: 6 months post-randomization

Scale will be used to assess specific medication-taking behaviors.

Diet Score on the Rapid Eating and Activity Assessment for Participants

Time Frame: 6 months post-randomization

Dietary intake will be assessed.

Self-Monitoring Behavior Using the Summary of Diabetes Self-Care Activities

Time Frame: 6 months post-randomization

This will be done to assess self-management behaviors for diabetes.

Secondary Outcomes

  • Quality of Life Using the Medical Outcomes Study Short Form(6 months post-randomization)
  • Glycosylated Hemoglobin A1c (HbA1c)(6 months post-randomization)
  • Low-Density Lipoprotein Cholesterol (LDL-c)(6 months post-randomization)
  • Blood Pressure(6 months post-randomization)
  • Cardiovascular Disease (CVD) Risk Using the Framingham Risk Score(6 months post-randomization)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials